Parker Moss

Loading
Parker Moss

Parker Moss

Chief Commercial and Partnership Officer, Genomics England
Parker Moss is Chief Commercial Officer for Genomics England, a Department of Health organisation focussed on driving Genomic Medicine into the NHS, and accelerating Genomic research in industry and academia. Parker is responsible for commercial and academic partnerships with Biopharma, Universities and the life science ecosystem. Previously Parker served as a member of the executive team at Owkin, an AI/ML Cancer Research company focussed on federated learning. He was entrepreneur in residence at Fidelity’s life sciences and tech venture capital funds, F-Prime and EightRoads, where he led the investment in Owkin before joining the company. Parker was a CTO in the NHS, including technology leadership roles at Great Ormond Street and Virgin Care. Parker also holds several non-executive roles, including on Cancer Research UK's commercial board (CRT). Parker holds a degree in Physics and Philosophy from Durham University. Parker lives in London with his wife, dog and two daughters and outside of work his passion is classical music.
Sessions
  • “Future Surgery 2021 will be the first of its kind in the UK, drawing on the work our Commission on the Future of Surgery has done to predict the transformation in the medical care for millions of patients.”
    Andrew Reed, Chief Executive of the Royal College of Surgeons of England
  • “Driven by changes in digital technologies and our fast-evolving understanding of genomics, innovations are expected to affect how we undertake surgery, and how we train surgeons in future.”
    Andrew Reed, Chief Executive of the Royal College of Surgeons of England
  • "Alongside the conference organisers, CloserStill, we aim to deliver a high-quality event that will provide both professional development and discussion space for surgeons and their teams."
    Andrew Reed, Chief Executive of the Royal College of Surgeons of England
  • "We look forward to welcoming colleagues to what promises to be a very high-quality programme and an exciting two days of thought-provoking training and engagement with medical suppliers."
    Andrew Reed, Chief Executive of the Royal College of Surgeons of England

EVENT PARTNER


 

PLATINUM SPONSOR

Edinurgh

PLATINUM SPONSOR

CMR

PLATINUM SPONSOR

quilter

GOLD SPONSOR


 

GOLD SPONSOR


 

GOLD SPONSOR

Sony

Sustainability Sponsor

SPONSOR

AneticAid

SPONSOR


 

SPONSOR


 

SPONSOR

Creed Medical

SPONSOR

Corza Medical

SPONSOR


 

SPONSOR

Epiqar

SPONSOR

Fundamental Surgery

SPONSOR


 

SPONSOR

Intuitive

SPONSOR


 

SPONSOR


 

SPONSOR


 

SPONSOR


 

SPONSOR


 

SPONSOR

  • Open Medical

 

SPONSOR

  • 365 Healthcare

 

Event Supporter


 

Event Supporter


 

Event Supporter


 

Event Supporter

British Orthopaedic Association

Event Supporter


 

Event Supporter


 

Event Supporter


 

Event Supporter


 

Event Supporter

SSSIM

MEDIA PARTNER

CSJ

MEDIA PARTNER

Operating Theatre Journal